ASCO22 Gastrointestinal Cancer Updates | Chris Nevala-Plagemann, MD | University of Utah

(4:21)

ASCO22 Gastrointestinal Cancer Updates | Daniel Lin, MD, MSc | Sidney Kimmel Cancer Center

(2:20)

ASCO22 Colorectal Updates | Arturo Loaiza Bonilla, MD, MSEd, FACP | Capital Health Cancer Center

(4:24)

ASCO22 Colorectal Cancer Updates | Mark Lewis, MD | Intermountain Healthcare

(2:25)

GEJ Adenocarcinoma Treatment Based on ESOPEC Study | Daniel Catenacci, MD | ASCO22 GI Cancer Updates

(1:47)

ASCO22 Colorectal Cancer Updates | Jeremy Jones, MD | Mayo Clinic

(48)

ASCO22 GYN Cancer Updates | Dana Chase, MD, FACOG | Arizona Center for Cancer Care

(4:51)

ASCO22 by the Numbers

(18)

Updates ASCO22 Webinar

(1:2:46)

Please Join Us: 2022 Gastrointestinal Cancers Symposium

(59)

ASCO22 Colorectal Cancer Updates | Greg Botta, MD, PhD | University of San Diego

(5:4)

Molecular Testing in Unresectable Biliary Tract Cancer | Daniel Catenacci, MD | ASCO22 GI Updates

(1:37)

ASCO22: Key Posters on Advances in GI Oncology

(13:46)

Novel Therapies in GI Oncology at ASCO22

(15:33)

What Changes Monday Morning? | Gastrointestinal Cancers ASCO 2021 Review

(1:31:47)

ASCO22: Chris Manz, MD on AI in oncology | Dana-Farber Cancer Institute

(1:15)

ASCO22 Leukemia Updates | Michael Deininger, MD, PhD | Versiti

(6:47)

Phase 3 PARADIGM Trial Review | Anwaar Saaeed, MD | ASCO22 Colorectal Cancer Updates

(55)

Highlights in GI cancer at ASCO 2022

(54)